M. Arboix

2.4k total citations
93 papers, 2.0k citations indexed

About

M. Arboix is a scholar working on Small Animals, Pharmacology and Animal Science and Zoology. According to data from OpenAlex, M. Arboix has authored 93 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Small Animals, 22 papers in Pharmacology and 20 papers in Animal Science and Zoology. Recurrent topics in M. Arboix's work include Antibiotics Pharmacokinetics and Efficacy (19 papers), Helminth infection and control (19 papers) and Research on Leishmaniasis Studies (14 papers). M. Arboix is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (19 papers), Helminth infection and control (19 papers) and Research on Leishmaniasis Studies (14 papers). M. Arboix collaborates with scholars based in Spain, Chile and Italy. M. Arboix's co-authors include Jordi Alberola, Lluís Ferrer, Laia Solano‐Gallego, Carles Cristòfol, Cristina Riera, Josep Enric Valladares, Montserrat Gállego, Montserrat Portús, Anna Puigdemont and Belén Pérez and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

M. Arboix

93 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Arboix Spain 23 918 535 410 346 230 93 2.0k
Joon Wah Mak Malaysia 26 686 0.7× 219 0.4× 863 2.1× 99 0.3× 74 0.3× 207 2.8k
Jiang Zheng China 30 493 0.5× 268 0.5× 1.0k 2.5× 209 0.6× 163 0.7× 90 2.8k
Ronald A. Greenfield United States 24 199 0.2× 535 1.0× 204 0.5× 121 0.3× 75 0.3× 58 1.8k
Ivete Conchon‐Costa Brazil 24 702 0.8× 418 0.8× 341 0.8× 34 0.1× 56 0.2× 112 1.6k
L W Scheibel United States 22 507 0.6× 141 0.3× 233 0.6× 81 0.2× 24 0.1× 35 1.2k
Max Grögl United States 35 2.7k 3.0× 1.7k 3.2× 568 1.4× 66 0.2× 28 0.1× 76 3.3k
Yasutoshi Kido Japan 23 156 0.2× 322 0.6× 151 0.4× 74 0.2× 115 0.5× 111 1.7k
Roberto Cedillo‐Rivera Mexico 28 164 0.2× 148 0.3× 584 1.4× 123 0.4× 44 0.2× 56 2.0k
Danielle Légaré Canada 27 1.6k 1.7× 1.3k 2.4× 422 1.0× 36 0.1× 33 0.1× 37 2.1k
Wei‐Li Hsu Taiwan 25 171 0.2× 557 1.0× 39 0.1× 167 0.5× 74 0.3× 119 2.5k

Countries citing papers authored by M. Arboix

Since Specialization
Citations

This map shows the geographic impact of M. Arboix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Arboix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Arboix more than expected).

Fields of papers citing papers by M. Arboix

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Arboix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Arboix. The network helps show where M. Arboix may publish in the future.

Co-authorship network of co-authors of M. Arboix

This figure shows the co-authorship network connecting the top 25 collaborators of M. Arboix. A scholar is included among the top collaborators of M. Arboix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Arboix. M. Arboix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castells, G., et al.. (2007). Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats. The Veterinary Journal. 177(2). 297–299. 5 indexed citations
2.
Arboix, M., et al.. (2002). Disposition kinetics of tylosin administered intravenously and intramuscularly to pigs. Research in Veterinary Science. 73(2). 141–144. 20 indexed citations
3.
Pérez, R., et al.. (2002). Pharmacokinetics of Doramectin and Ivermectin After Oral Administration in Horses*. The Veterinary Journal. 163(2). 161–167. 27 indexed citations
4.
Intorre, Luigi, G. Castells, Carles Cristòfol, et al.. (2002). Residue depletion of thiamphenicol in the sea‐bass. Journal of Veterinary Pharmacology and Therapeutics. 25(1). 59–63. 8 indexed citations
5.
Solano‐Gallego, Laia, Joan Llull, M. Arboix, Lluís Ferrer, & Jordi Alberola. (2001). Evaluation of the efficacy of two leishmanins in asymptomatic dogs. Veterinary Parasitology. 102(1-2). 163–166. 21 indexed citations
6.
Valladares, Josep Enric, Cristina Riera, Laia Solano‐Gallego, et al.. (2001). Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation. Veterinary Parasitology. 97(1). 15–21. 36 indexed citations
7.
Carrió, Jaume, Marı́a Colmenares, Cristina Riera, et al.. (2000). Leishmania infantum: Stage-Specific Activity of Pentavalent Antimony Related with the Assay Conditions. Experimental Parasitology. 95(3). 209–214. 41 indexed citations
8.
Cristòfol, Carles, G. Virkel, Luis Ignacio Ortega Álvarez, M. Arboix, & Carlos Lanusse. (2000). Comparative disposition of ricobendazole enantiomers after intravenous and subcutaneous administration of a racemic formulation to calves. Biopharmaceutics & Drug Disposition. 21(8). 303–311. 21 indexed citations
9.
Cristòfol, Carles, et al.. (1998). Sex differences in the disposition of albendazole metabolites in sheep. Veterinary Parasitology. 78(3). 223–231. 20 indexed citations
10.
Cabanes, Anna, et al.. (1998). Evaluation of free and liposome-encapsulated gentamycin for intramuscular sustained release in rabbits. Research in Veterinary Science. 64(3). 213–217. 17 indexed citations
11.
Castells, G., et al.. (1998). Pharmacokinetics of thiamphenicol in dogs. American Journal of Veterinary Research. 59(11). 1473–1473. 9 indexed citations
12.
Castells, G., et al.. (1997). Pharmacokinetics of thiamphenicol in dogs. Journal of Veterinary Pharmacology and Therapeutics. 20(11). 61–61. 3 indexed citations
13.
Valladares, Josep Enric, et al.. (1997). Pharmacokinetics of Liposome-Encapsulated Meglumine Antimonate after Intramuscular and Subcutaneous Administration in Dogs. American Journal of Tropical Medicine and Hygiene. 57(4). 403–406. 15 indexed citations
14.
Navarro, Marc, et al.. (1996). Effect of the acidosis on the degenerating mesonephric vascular system of the chick embryos. The International Journal of Developmental Biology. 40(S1). S287–S288. 1 indexed citations
15.
Cristòfol, Carles, et al.. (1995). Bupivacaine disposition and pharmacologic effects after intravenous and epidural administrations in dogs. American Journal of Veterinary Research. 56(8). 1087–1091. 20 indexed citations
16.
Puigdemont, Anna, Joaquim Ramis, Raimón Guitart, & M. Arboix. (1993). Species Scaling of Propafenone Disposition and Concentration–Time Relationships among Eight Mammalian Species. Journal of Pharmaceutical Sciences. 82(11). 1126–1129. 3 indexed citations
17.
Cabanes, Anna, et al.. (1992). Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. American Journal of Veterinary Research. 53(11). 2090–2093. 42 indexed citations
18.
Puigdemont, Anna, Raimón Guitart, Fernando de Mora, & M. Arboix. (1991). Prediction of the Disposition of Propafenone in Humans and Dogs from Pharmacokinetic Parameters in Other Animal Species. Journal of Pharmaceutical Sciences. 80(12). 1106–1109. 14 indexed citations
19.
Puigdemont, Anna, J. Riu, Raimón Guitart, & M. Arboix. (1990). Propafenone kinetics in the horse. Journal of Pharmacological Methods. 23(2). 79–85. 8 indexed citations
20.
Puigdemont, Anna, et al.. (1987). Pharmacokinetics of propafenone in the dog after single‐dose intravenous administration. Journal of Veterinary Pharmacology and Therapeutics. 10(4). 351–353. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joon Wah Mak Breakdown of academic impact, for papers by Jiang Zheng Breakdown of academic impact, for papers by Ronald A. Greenfield Breakdown of academic impact, for papers by Ivete Conchon‐Costa Breakdown of academic impact, for papers by L W Scheibel Breakdown of academic impact, for papers by Max Grögl Breakdown of academic impact, for papers by Yasutoshi Kido Breakdown of academic impact, for papers by Roberto Cedillo‐Rivera Breakdown of academic impact, for papers by Danielle Légaré Breakdown of academic impact, for papers by Wei‐Li Hsu
Rankless by CCL
2026